Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

Vaccine
T VesikariB De Vos

Abstract

A live attenuated human rotavirus (HRV) vaccine, strain RIX4414, was tested sequentially in adults, previously infected toddlers, and previously uninfected infants. A single dose was given to adults and toddlers and found well tolerated. Next, a dose ranging (three different viral concentrations) safety and immunogenicity study was conducted in rotavirus IgA antibody negative infants (N= 192), who received two doses of RIX4414 vaccine or placebo at 2 and 4 months of age. No side effects were seen after vaccination. Specifically, administration of RIX4414 vaccine was not temporally associated with fever, diarrhea, or increase in liver transaminases. Rotavirus IgA seroconversion ranged from 50 to 88% after one dose and from 73 to 96% after two doses, depending on vaccine titer. After the first dose, on days 7-9 post vaccination, between 38 and 60% of the infants shed the vaccine virus, whereas after the second dose only 0 to 13% of the vaccinees shed the vaccine virus. It is concluded that RIX4414 strain HRV vaccine is virtually non-reactogenic and, at high titer, highly immunogenic in susceptible infants.

References

Jan 1, 1978·Journal of Medical Virology·T KonnoM Adachi
Aug 1, 1991·The Journal of Infectious Diseases·D I BernsteinR L Ward
Aug 1, 1991·American Journal of Diseases of Children·D J IngA J Sievert
Apr 1, 1988·The Journal of Pediatrics·K GrimwoodG L Barnes
Nov 1, 1986·Journal of Pediatric Gastroenterology and Nutrition·A KovacsB Portnoy
Aug 1, 1993·The Journal of Infectious Diseases·M K BhanR I Glass
Sep 1, 1996·The Journal of Infectious Diseases·R L Ward
Sep 1, 1996·The Journal of Infectious Diseases·T Vesikari, J Joensuu
Oct 3, 1996·The New England Journal of Medicine·F R VelázquezG M Ruiz-Palacios
Oct 23, 1997·The New England Journal of Medicine·I Pérez-SchaelA Z Kapikian
Dec 6, 1997·Lancet·T Vesikari
May 12, 1998·The Pediatric Infectious Disease Journal·J JoensuuT Vesikari
May 15, 1998·JAMA : the Journal of the American Medical Association·A W TuckerR I Glass
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A K TakalaT Vesikari
Nov 5, 1998·The Pediatric Infectious Disease Journal·M B RennelsR I Glass
Nov 17, 1998·The Journal of Infectious Diseases·L H MoultonR L Ward
Nov 30, 1999·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)
Oct 6, 2000·Microbiology and Immunology·T Nakagomi
Nov 9, 2000·The Journal of Infectious Diseases·F R VelázquezG M Ruiz-Palacios
Feb 24, 2001·The New England Journal of Medicine·T V MurphyUNKNOWN Rotavirus Intussusception Investigation Team
May 3, 2001·The Pediatric Infectious Disease Journal·P KramarzJ M Ogren
May 18, 2001·The New England Journal of Medicine
Nov 29, 2001·American Journal of Epidemiology·T VerstraetenUNKNOWN Vaccine Adverse Event Reporting System Team
May 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Baoming JiangRoger I Glass
Oct 31, 2002·The Journal of Infectious Diseases·David I BernsteinRichard L Ward
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·D I Bernstein

❮ Previous
Next ❯

Citations

Feb 25, 2014·Vaccine·Pamela AidelsburgerOle Wichmann
Sep 29, 2006·Journal of Virology·Kelly L WarfieldMargaret E Conner
Jan 18, 2007·TreatmentUpdate
Oct 27, 2004·The Pediatric Infectious Disease Journal·Beatrice De VosKarin Hardt
Dec 17, 2004·The Pediatric Infectious Disease Journal·Timo VesikariBeatrice De Vos
Jan 7, 2006·The Pediatric Infectious Disease Journal·Timo VesikariHans-Iko Huppertz
Jan 10, 2012·The Pediatric Infectious Disease Journal·Timo VesikariHtay Htay Han
Mar 12, 2009·Journal of Tropical Pediatrics·Nicholas M KiuliaJason M Mwenda
Jul 3, 2010·Paediatric Drugs·Keith GrimwoodRichard J Milne
May 9, 2008·Journal of Pediatric Gastroenterology and Nutrition·Jacek MrukowiczUNKNOWN European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
May 22, 2008·Journal of Pediatric Gastroenterology and Nutrition·Timo VesikariUNKNOWN European Society for Paediatric Gastroenterology, Hepatology, and Nutrition
Nov 20, 2013·Health Economics Review·Stefanie KnollBaudouin Standaert
Jan 18, 2006·Annual Review of Medicine·Alan R Shaw
Jan 6, 2006·The New England Journal of Medicine·Guillermo M Ruiz-PalaciosUNKNOWN Human Rotavirus Vaccine Study Group
Nov 30, 2005·Transgenic Research·Eric SolerLouis-Marie Houdebine
Dec 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Richard L Ward, David I Bernstein
Dec 17, 2008·Scandinavian Journal of Infectious Diseases·Timo Vesikari
Dec 1, 2009·Expert Review of Vaccines·Miguel O'Ryan, Alexandre C Linhares
Feb 7, 2007·Expert Review of Vaccines·Miguel O'Ryan
Oct 4, 2013·Expert Opinion on Biological Therapy·Osamu NakagomiNigel A Cunliffe
Jul 14, 2009·Expert Opinion on Biological Therapy·Toyoko Nakagomi, Osamu Nakagomi
May 22, 2009·Gastroenterology·Harry B Greenberg, Mary K Estes
Feb 10, 2006·Pediatric Annals·David I Bernstein, Richard L Ward
Sep 1, 2015·The Lancet Infectious Diseases·Timo Vesikari
Mar 30, 2007·Marine Pollution Bulletin·Dimitrios A Georgakellos
Oct 24, 2006·Seminars in Pediatric Infectious Diseases·David I Bernstein
Jul 25, 2006·Lancet·Roger I GlassJon R Gentsch
Nov 30, 2005·Archives of Medical Research·Jimena Pérez-VargasCarlos F Arias
Nov 24, 2007·Expert Opinion on Biological Therapy·Philippe Lepage, Anne Vergison
Apr 11, 2015·The Pediatric Infectious Disease Journal·Timo VesikariVytautas Usonis
Jul 14, 2010·Human Vaccines·Victoria JiangManish M Patel
Oct 12, 2010·Vaccine·Birgitte Freiesleben de BlasioElmira Flem

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.